NCT05163548View on ClinicalTrials.gov

PerQseal®+ Early Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
Percutaneous Large Hole Vascular Closure
Interventions
DEVICE

PerQseal Plus Device

Percutaneous closure of femoral artery access site created by 14 to 22 F sheaths (up to 26 F arteriotomy) in patients undergoing Percutaneous Transcatheter procedures.

Trial Locations (5)

10021

Weill Cornell Medicine, New York

10032

Lankenau Heart Institute, Wynnewood

10467

Montefiore Hospital, The Bronx

11794

Stony Brook University Hospital, Stony Brook

07450

The Valley Hospital, Ridgewood

All Listed Sponsors
lead

Vivasure Medical Limited

INDUSTRY